Back to News
Market Impact: 0.1
MetaVia Appoints Sarah Browne As CMO
Source: Nasdaq
Healthcare & BiotechManagement & Governance
MetaVia Inc., a clinical-stage biotechnology company, appointed Sarah Browne as Chief Medical Officer, effective October 12. The article provides no further details on the appointment or its expected impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
MTVA0.20
More News
- FBI arrests OpenAI employee accused of planting secret recording device in conference room
- How tech icon Meg Whitman is already leaving her mark on grocery giant Albertsons
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
- UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
- Liquidia (NASDAQ:LQDA) CMO Rajeev Saggar disposes of $262,528 in stock
- Rhythm Pharmaceuticals launches IMCIVREE in Japan for obesity